• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Phastar Appoints Chris Schoonmaker as Chief Operations Officer

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills

    Batavia Enters Commercial Manufacturing Business

    CoreRx Expands Capabilities

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Vector Partners Limited

    Quotient Sciences

    IDT Biologika

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Vector Partners Limited

    Quotient Sciences

    IDT Biologika

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Parenteral Drug Delivery Trends

    A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.

    Parenteral Drug Delivery Trends
    Parenteral Drug Delivery Trends
    Rob Lee, Lubrizol Life Science Health’s CDMO Division President.
    Related CONTENT
    • Bora Pharmaceuticals
    • Legacy Pharma Solutions
    • Vio Chemicals
    • Aenova
    • Curia
    Kristin Brooks, Managing Editor, Contract Pharma01.27.21
    The CDMO Division of Lubrizol Life Science Health (LLS Health) is a pharmaceutical contract development and drug product manufacturing organization that offers a range of technical capabilities, multiple technology platforms, and expertise in complex drug delivery.

    LLS Health offers R&D formulation and clinical/commercial drug product manufacturing supported by analytical testing, ICH stability programs, and HPAPI/controlled substance handling. Its technology-agnostic team offers expertise in solubility and bioavailability enhancement, sterile and aseptic manufacturing, and long-acting injectables and implantables.

    Contract Pharma recently caught up with the president of LLS Health, Rob Lee, and talked about the CDMO’s continued growth alongside the rise of biologics and parenteral drug delivery and technology trends in general.

    Contract Pharma (CP): In what services areas are you seeing the most growth?

    Rob Lee (RL): Currently, drug delivery is a significant area of growth, particularly parenteral drug delivery. We have seen a lot of advancement in pre-filled syringes, continuing the trend in healthcare for the past decade towards home healthcare and self-administration of injectables. The rise in insoluble small molecules and biologics is also driving this trend towards parenteral drug delivery.

    At LLS Health, we have seen a lot of interest in companies looking for small batch size commercial manufacturing capacity. This may not be a sweet spot for larger CDMOs who have traditionally designed their manufacturing lines to serve high volume, blockbuster drug products. LLS Health, in contrast, has designed unique manufacturing facilities to accommodate small batch commercial manufacturing and flexible systems to serve the growth of biologics, orphan drug products, and personalized medicine, as well as traditional drug products.

    CP: What are some of the latest technology platforms being leveraged in these service areas?

    RL: Linked to the rise in parenterals, we have seen an increased market interest in more patient centric dosage forms such as infusion-type wearable devices. We have seen growth in highly viscous liquid products that are used in these devices, particularly for biologics, which has led us to re-examine and reconfigure existing technologies that we run in filling operations. These changes meant we had to look at the allotment, filtration, and dosing to retool from an operational and validation standpoint to ensure a consistent product.

    We selected equipment that utilizes tub-filling to accommodate flexible GMP manufacturing.  This technology allows us to fill many different types of primary packaging such as vials, syringes, cartridges, and bottles.

    In addition, there continues to be growing interest in long-acting injectables that can help cut down the number of injections that a patient requires for a given treatment. These are lyophilized products that are reconstituted to form a depot in the body and rely on much of the same expertise as viscous biologic formulations.

    CP: What are the key considerations in designing and executing aseptic processes?

    RL: It is preferable to use closed systems as much as possible. Even when working with an open system and executing manual aseptic processes, it is essential to understand the process and have an experienced, proven engineering team in place to design it and ensure the use of appropriate validation methods to support it. Otherwise the risk of failure due to microbial contamination increases.

    And, of course, aseptic process simulations or media fills must take place prior to an aseptic fill. Media fills involve challenging an aseptic process using a sterile microbiological growth medium to ensure a process prevents contamination during actual production. During a media fill for a new process, the fill is performed three consecutive times to check sterility assurance across the totality of the process, including personnel, equipment, packaging, and manufacturing steps. Any change to an aseptic process may require revalidation, so partnering with a CDMO that has experience and media fill strategy helps ensure aseptic validation does not end up being a drain on project funds and resources.

    CP: What are the main challenges when performing aseptic lyophilization and how can they be overcome?

    RL: A major consideration when dealing with a sterile lyophilized product that is manufactured aseptically is maintaining an ISO 5, Grade A environment for the partially stoppered vials to avoid contamination. This either requires a lyophilizer that is maintained in an ISO 5, Grade A area or the use of isolator technology. At the LLS Health facility, to maintain the greatest amount of flexibility, we have opted to build an ISO 5 Grade A room for our lyophilizer allowing us to incorporate many different technologies. 

    Another challenge centers on formulation considerations related to the continued growth of mixed solvent systems and the use of organics, such as t-butanol. Attempting to remove these solvents and organics during lyophilization poses a challenge, as most lyophilizers are designed to remove water as the primary solvent. To address this challenge, we elected to modify our lyophilizer to include an inline condenser unit to remove the solvent so that the solvent doesn’t liquify in the main condenser or leave the system. 

    CP: What kind of growth are you seeing for aseptic lyophilization for biologics and complex drug products?

    RL: We are seeing significant growth in small batch size complex parenteral drug products, including biologics and nanoparticulate suspensions. The key here is to understand and control the formulation and lyophilization process. 

    For biologics, it is critical to ensure that molecules maintain their three-dimensional structure/conformation and avoid aggregation upon reconstitution. This requires strict control over processing parameters during manufacturing steps such as mixing, filtration, and filling. A well-designed process ensures that large molecule APIs maintain their biological activity and can be properly administered from devices like pre-filled syringes.

    For nanoparticulate suspensions, the key is maintaining the same particle size pre- and post-reconstitution. Developing particulate-based products often requires specialized formulation and analytical techniques to characterize particles and ensure they are unchanged by the lyophilization process. Therefore, it important to work with an organization that has experience in nanoparticulate suspensions and who has worked on many nanomilled products over the years.

    LLS Health has experience working with biologics and nanoparticulate suspensions, giving us access to the formulation techniques, excipients, and characterization tools to specifically address stability and aggregation challenges in a manufacturing setting. For example, a customer who was developing a challenging nanoparticulate-based ophthalmic product approached LLS Health for process optimization and scale-up support. LLS Health’s experience with nanoparticulate suspensions guided formulation development, resulting in a reproducible, highly concentrated, and stable nanoparticulate intermediate. Our team then designed a scaled-up, aseptic manufacturing process and is currently working with the customer to validate the process. This project required LLS Health’s unique nanoparticulate knowledge and our experience with sterile product manufacturing—a rare, but valuable, combination of CDMO services that enabled success. 


    Dr. Rob Lee is president of the CDMO Division of Lubrizol Life Science Health (LLS Health) where he is responsible for product and business development along with providing strategic direction. Before joining LLS Health, Rob held senior management positions at Novavax, Lyotropic Therapeutics and Imcor Pharmaceutical. He has over 30 years of experience in pharmaceutical research and development of both therapeutic drugs and diagnostic imaging agents and has published more than three dozen articles and five book chapters plus holds 11 issued patents and 15 provisional or PCT patent applications. 
    Suggested For You
    Bora Pharmaceuticals Bora Pharmaceuticals
    Legacy Pharma Solutions Legacy Pharma Solutions
    Vio Chemicals Vio Chemicals
    Aenova Aenova
    Curia Curia
    ViscoTec America Inc. ViscoTec America Inc.
    MedPharm MedPharm
    PCI Pharma Services PCI Pharma Services
    Sekisui Sekisui
    PCI Synthesis PCI Synthesis
    Seqens CDMO North America Seqens CDMO North America
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities

    Related Content

    • Bora Pharmaceuticals

      Bora Pharmaceuticals

      ...
      Lonnie Barish, VP, Business Development 03.09.22

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Vio Chemicals

      ...
      Ioanna Kazantzidou, Marketing Communications Officer 12.07.21


    • Aenova

      Aenova

      ...
      Susanne Knabe, Head of Communication & PR 11.30.21

    • cGMP Manufacture | Chemistry
      Curia

      Curia

      ...
      Cheryl Cook, Marketing Communications Manager 11.10.21

      Loading, Please Wait..
      Trending
      • Regulatory Report: Analytical Procedure Development
      • Pierre Fabre And Lonza Enter Manufacturing Agreement
      • Pfizer, BioNTech Adapt COVID Vax Against Omicron
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      • Shimadzu Scientific Instruments Extends HQ Campus
      Breaking News
      • Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      • Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      • EQT Private Equity Acquires SPT Labtech from Battery Ventures
      • Shimadzu Scientific Instruments Extends HQ Campus
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Kensing Acquires Vitae Naturals
      CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
      Shiitake Mushroom Extract Appears Helpful in HPV Infections
      Coatings World

      Latest Breaking News From Coatings World

      Sheboygan Paint Company Adds Rosey Malchow as Customer Experience Manager
      PPG to Announce Second Quarter 2022 Results July 21
      Evonik Unveils Range of Sustainable Liquid Polybutadienes
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Researchers Develop New Apparatus for the Treatment of Cardiovascular Diseases
      NovaXS Unveils New Prototype of Needle-Free Injection Therapy Smart Medical Device
      Meddux Opens New Facility in Boulder, Colorado
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      EQT Private Equity Acquires SPT Labtech from Battery Ventures
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Highlights from Paris Packaging Week
      Walgreens Boots Alliance Decides Not to Sell Boots and No7 Beauty Company Businesses
      WWP Beauty Unveils New Packaging Collections in Collaboration with Eastman
      Happi

      Latest Breaking News From Happi

      Evonik Holds Groundbreaking Ceremony for Commercial Rhamnolipid Production Facility
      CHT USA Hosts Groundbreaking Ceremony for $20 Million US Headquarters Expansion
      Azelis Expands Global Flavors & Fragrances Platform with Acquisition in India
      Ink World

      Latest Breaking News From Ink World

      Temporary Content Title
      Amcor Lift-Off Initiative Shortlists Start-ups for Seed Funding
      Barentz Highlights Lincoln MFG’s New ISO 9001:2015 Certification
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Sibress launches FADS3D flexo plate measuring device
      Mike Brown appointed VP for Davis-Standard’s Canadian operations
      Constantia Flexibles introduces chemical resistant recycle-ready laminate
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Suominen Launches Hydraspun Reserve
      Richard Knowlson Receives Lifetime Technical Achievement Award
      Skylark Launches Thicker Label Closure Technology in North American
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Tecomet Appoints Bill Dow as President & CEO
      Medacta, InSilicoTrials Partner on Orthopedic Device Development
      Researchers Develop Microfluidic Sensors to Improve Implant Survival Rates
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Avery Dennison Launches New Dual-Frequency RFID Inlay
      Avery Dennison Highlights New Approach to Apparel with ADX Lab
      trinamiX Face Authentication Protects Users from Fraud Attacks During Mobile Payments

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login